Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01362673
What this trial is testing

PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions

Who this might be right for
Healthy
Pfizer 27
Early research (Phase 1)Study completedNCT03198182
What this trial is testing

Test the Effects of BMS-986036 on the Body in Healthy Japanese and Non-Japanese Subjects

Who this might be right for
Metabolics
Bristol-Myers Squibb 63
Early research (Phase 1)Study completedNCT07600762
What this trial is testing

Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants

Who this might be right for
Healthy Volunteer
AbbVie 12
Early research (Phase 1)Study completedNCT00458107
What this trial is testing

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects

Who this might be right for
Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer 64
Early research (Phase 1)Study completedNCT02770521
What this trial is testing

Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants

Who this might be right for
Healthy
Eli Lilly and Company 23
Early research (Phase 1)Study completedNCT03150108
What this trial is testing

Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects

Who this might be right for
Hypoparathyroidism
Shire 24
Post-approval studies (Phase 4)Study completedNCT01926015
What this trial is testing

Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060)

Who this might be right for
Rotavirus Disease
Merck Sharp & Dohme LLC 192
Early research (Phase 1)Study completedNCT01620476
What this trial is testing

Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 24
Early research (Phase 1)Study completedNCT00822185
What this trial is testing

Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers

Who this might be right for
Congenital Bleeding DisorderHealthy
Novo Nordisk A/S 32
Post-approval studies (Phase 4)Study completedNCT03667547
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC 12
Early research (Phase 1)Study completedNCT04542252
What this trial is testing

Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects

Who this might be right for
Drug Drug Interaction
SymBio Pharmaceuticals 13
Early research (Phase 1)Study completedNCT05590338
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 38
Early research (Phase 1)Study completedNCT02207790
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects

Who this might be right for
Healthy Subjects
Eisai Inc. 32
Early research (Phase 1)Study completedNCT05405543
What this trial is testing

Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 36
Early research (Phase 1)Study completedNCT05684289
What this trial is testing

A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 61
Early research (Phase 1)Study completedNCT01835197
What this trial is testing

First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects

Who this might be right for
Healthy
Pfizer 79
Not applicableLooking for participantsNCT07393126
What this trial is testing

Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults

Who this might be right for
Healthy Japanese
Indena S.p.A 76
Early research (Phase 1)Study completedNCT01424163
What this trial is testing

Dexpramipexole Japanese PK Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 57
Early research (Phase 1)Study completedNCT01843556
What this trial is testing

E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males

Who this might be right for
Healthy Elderly Male
Eisai Co., Ltd. 48
Early research (Phase 1)WithdrawnNCT01691872
What this trial is testing

Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects

Who this might be right for
Epilepsy, Partial
GlaxoSmithKline
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation